当前位置: 首页 >> 检索结果
687. Summaries for Patients: Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention.
来源: Ann Intern Med. 2016年164卷6期I34页
690. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.
Update of the 2009 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for breast cancer.
691. Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force.
作者: Joy Melnikow.;Joshua J Fenton.;Evelyn P Whitlock.;Diana L Miglioretti.;Meghan S Weyrich.;Jamie H Thompson.;Kunal Shah.
来源: Ann Intern Med. 2016年164卷4期268-78页
Screening mammography has lower sensitivity and specificity in women with dense breasts, who experience higher breast cancer risk.
693. Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data.
作者: Heidi D Nelson.;Ellen S O'Meara.;Karla Kerlikowske.;Steven Balch.;Diana Miglioretti.
来源: Ann Intern Med. 2016年164卷4期226-35页
Women screened with digital mammography may receive false-positive and false-negative results and subsequent imaging and biopsies. How these outcomes vary by age, time since the last screening, and individual risk factors is unclear.
695. Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation.
作者: Heidi D Nelson.;Miranda Pappas.;Amy Cantor.;Jessica Griffin.;Monica Daeges.;Linda Humphrey.
来源: Ann Intern Med. 2016年164卷4期256-67页
In 2009, the U.S. Preventive Services Task Force recommended biennial mammography screening for women aged 50 to 74 years and selective screening for those aged 40 to 49 years.
696. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
作者: Jeanne S Mandelblatt.;Natasha K Stout.;Clyde B Schechter.;Jeroen J van den Broek.;Diana L Miglioretti.;Martin Krapcho.;Amy Trentham-Dietz.;Diego Munoz.;Sandra J Lee.;Donald A Berry.;Nicolien T van Ravesteyn.;Oguzhan Alagoz.;Karla Kerlikowske.;Anna N A Tosteson.;Aimee M Near.;Amanda Hoeffken.;Yaojen Chang.;Eveline A Heijnsdijk.;Gary Chisholm.;Xuelin Huang.;Hui Huang.;Mehmet Ali Ergun.;Ronald Gangnon.;Brian L Sprague.;Sylvia Plevritis.;Eric Feuer.;Harry J de Koning.;Kathleen A Cronin.
来源: Ann Intern Med. 2016年164卷4期215-25页
Controversy persists about optimal mammography screening strategies.
697. Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation.
作者: Heidi D Nelson.;Rochelle Fu.;Amy Cantor.;Miranda Pappas.;Monica Daeges.;Linda Humphrey.
来源: Ann Intern Med. 2016年164卷4期244-55页
In 2009, the U.S. Preventive Services Task Force recommended biennial mammography screening for women aged 50 to 74 years and selective screening for those aged 40 to 49 years.
698. Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study.
作者: Diana L Miglioretti.;Jane Lange.;Jeroen J van den Broek.;Christoph I Lee.;Nicolien T van Ravesteyn.;Dominique Ritley.;Karla Kerlikowske.;Joshua J Fenton.;Joy Melnikow.;Harry J de Koning.;Rebecca A Hubbard.
来源: Ann Intern Med. 2016年164卷4期205-14页
Estimates of risk for radiation-induced breast cancer from mammography screening have not considered variation in dose exposure or diagnostic work-up after abnormal screening results.
699. The Effect of Treatment Advances on the Mortality Results of Breast Cancer Screening Trials: A Microsimulation Model.
作者: Jeanette Birnbaum.;Vijayakrishna K Gadi.;Elan Markowitz.;Ruth Etzioni.
来源: Ann Intern Med. 2016年164卷4期236-43页
Mammography trials, which are the primary sources of evidence for screening benefit, were conducted decades ago. Whether advances in systemic therapies have rendered previously observed benefits of screening less significant is unknown.
|